Chronic inflammatory demyelinating polyneuropathy presenting as Guillain–Barre syndrome: A case presentation
Loading...
Date
2019-06
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
International Journal of Medical Science and Public Health
Abstract
Guillain–Barre syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP) are immune-related neuropathies and differentiated mainly by disease course. GBS is characterized by a monophasic course, with a clinical nadir within 4 weeks of symptom onset, whereas CIDP typically demonstrates a slowly progressive course with gradual worsening over more than an 8-week period. Both may share common features such as demyelinating polyneuropathy, raised protein in cerebrospinal fluid, and conduction delay or block in nerve conduction study. Here, we present a case who was diagnosed and managed as GBS based on history, clinical presentation, and electrodiagnostic criteria on initial visit. Later on, we revised our diagnosis to acute-CIDP when the patient deteriorated after 8 weeks. This subset of the patient (up to 16% of CIDP) may initially present as GBS. Distinguishing between GBS and CIDP is crucial as prognosis and treatment differ.
Description
Keywords
Neuropathies, Monophasic, Demyelinating, Nerve Conduction Study, Deterioration
Citation
Bhattachrjee S. Chronic inflammatory demyelinating polyneuropathy presenting as Guillain–Barre syndrome: A case presentation. International Journal of Medical Science and Public Health. 2019 Jun; 8(6): 482-484